| # | Drug | Count |
|---|---|---|
| 0 | TRASTUZUMAB | 14 |
| 1 | DOCETAXEL | 13 |
| 2 | DOCETAXEL ANHYDROUS | 13 |
| 3 | PERTUZUMAB | 9 |
| 4 | ADO-TRASTUZUMAB EMTANSINE | 6 |
| 5 | NIVOLUMAB | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADO-TRASTUZUMAB EMTANSINE | 6 | 0.0007 |
| 1 | PERTUZUMAB | 9 | 0.0003 |
| 2 | TRASTUZUMAB | 14 | 0.0002 |
| 3 | DOCETAXEL | 13 | 0.0002 |
| 4 | DOCETAXEL ANHYDROUS | 13 | 0.0002 |
| 5 | NIVOLUMAB | 4 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | HER2/neu Receptor Antagonist [EPC] | 14 |
| 1 | Microtubule Inhibitor [EPC] | 13 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | HER2/neu Receptor Antagonist [EPC] | 14 | 0.0002 |
| 1 | Microtubule Inhibitor [EPC] | 13 | 0.0001 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 4 | 0.0000 |